Presentation is loading. Please wait.

Presentation is loading. Please wait.

DIABETIC EMERGENCIES Trevor Langhan MD January 31 st, 2008 University of Calgary.

Similar presentations


Presentation on theme: "DIABETIC EMERGENCIES Trevor Langhan MD January 31 st, 2008 University of Calgary."— Presentation transcript:

1 DIABETIC EMERGENCIES Trevor Langhan MD January 31 st, 2008 University of Calgary

2 Objectives Case based approach to important glucose related presentations Mixed in with some physiology to understand treatment plans

3 Case 1 21 year old Japanese exchange student In Canada past 6 months Felt sick for past 2 days and was not eating Now billeting family says he is acting confused

4 Case 1 In to ED via EMS Pt too drowsy to provide accurate history Responds to pain Thin male, looks dehydrated PMHx: Type 1 DM since 6 yrs old Questions?

5 Case 1 Vitals:  T – 38.2  HR – 130  BP – 100/60  RR – 28  Sats – 98% Bedside tests:  Chemstrip – “high” Additional labs?

6 Case 1 Na+ 130 K+ 6.3 HCO 8 Cl 108 Cr 165 Glucose 38 What is his AG?  14 – is this right?

7 Na+ correction for increase Glucose Multiple sources of information for formula…. Common:  Increase Na+ 1.6 for every 5.6 mmol/L glucose Easiest:  Increase Na+ 3 mmol/L for every 10 mmol/L of glucose

8 Na+ correction for increase Glucose Hyperglycemia (and hyperlipidemia) leads to increase in osmolar funciton of blood H20 is drawn from the cells into the vascular space Dilutional hyponatremia For our guy his Na+ = 139 mmol/L  3 mmol increase Na+ / 10 mmol glucose

9 Case 1 With the new Na+ his AG is actually 23 So he has an anion gap metabolic acidosis…. How are you going to get his acid/base status? ABG vs. VBG…..

10 Ma OJ et al. Arterial Blood Gas Results Rarely Influence Emergency Physician Management of Patients with Suspected Diabectic Ketoacidosis. Acad Emerg Med. Aug 2003, 10:8. Prospective observational study Inclusion: DKA pts VBG, ABG, chem 6 ABG result changed:  Altered treatment in 7/200 (3.5%, 1.7-7.1% CI)  dispostion in 2/200 cases (1%, 0.3-3.6% CI) VBG pH correlated with ABG pH (r = 0.951)

11 Case 1 What is the source of his gap acidosis?  Ketone production from fatty acid breakdown How are you going to prove that?  Urine vs. blood….

12 Urine vs. blood Urine dip stick  Nitroprusside reaction Qualitatively assess for ketones  Only measures which ketone?  Acetoacetate  Does not measure B-Hydroxy Buterate AA:BHB ratio is 1:3 (can be as high as 1:30) So might have false –ve urine dip despite gross ketosis

13 Case 1 So you’ve proven he’s got an AGMA And shown where the acidosis is coming from…. Dx: Diabetic ketoacidosis

14 DKA - Diagnosis Clinical  Dehydration  High cap glucose  Ketones in urine or plasma Confirmed:  Blood pH  Serum Bicarb  Serum Osmolality

15

16 DKA Three main problems: 1. Hyperglycemia Osmotic diuresis Dehydration – can be profound 5-7 litre total fluid deficit 2. Loss of electrolytes K+, Na+, Mg+, PO4- 3. Acidosis Transcelluar shift of H+ and K+ Falsely normal K+ (or even high)

17 DKA - Treatment Fluid rehydration  Pts in hypovolemic shock need assessment of ABCs  Treat with boluses of 0.9% NS  Avoid pressors – etiology of shock is decreased intravascular volume  Adults – 1-2 litres over 1 hour  Subsequent fluid change to 0.45% NS

18 DKA- Treatment Peds – 20 cc/kg bolus initially if shock Otherwise start with 10 cc/kg Goal to replace fluid deficit over 24-48 hours Dreaded risk of cerebral edema….

19 Multi-center, retrospective Included DKA pts with CE Matched for illness severity to DKA pts with no CE Log regression Risk Factors:  High urea  Use of Bicarb  Low PCO2

20 Why do they get Cerebral Edema?

21 Marcin JP et al. Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema. Journal of Pediatrics. 141(6); Dec 2002. 3 variables were found to be associated with a poor outcome of children with DKA-related cerebral edema  Elevated initial BUN concentration  More profound neurologic depression at the time of diagnosis of cerebral edema  Intubation with associated hyperventilation to a PCO2 level <22 mm Hg.

22 DKA - Treatment Boluses of fluid to increase intravascular volume What next? Stop lipolysis and the production of ketone bodies  His glucose is 38 mmol/L  How do you want to treat him?

23 DKA - Treatment IV regular insulin is the start No RCT to prove bolus vs. just starting an infusion Current practice is to only start an infusion at 0.1 unit/kg/hour No need to quickly drive glucose into the cells  Rehydration and osmotic diuresis will eliminate most excess glucose

24 Umpierrez GE et al. Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Nonketotic Syndrome. Am J Med Sci. 311(5); May 1996, pp 225-233. Kitabchi et al. Compare ‘high dose’ to ‘low dose insulin’ in DKA treatment RCT, prospective No difference in:  Rate of decline of blood glucose  Rate of decline of ketone body concentration  Time to resolve acidosis High doses of insulin associated with:  25% increase in hypoglycemic events  Greater hypokalemia

25 DKA - Treatment Current standard has become ‘low dose’ insulin Constant infusion at 0.1 units/kg No current need to bolus administer insulin

26 DKA - Treatment As glucose is trending down add a glucose containing solution to IV fluid  Glucose < 14 mmol/L  Drop insulin infusion by 50%  Add D5 to your ½ NS maintenance Run at 200-400 cc/hr for first 12 hours

27 Loss of Electrolytes

28 Electrolyte Replacement Loss of:  Cl-, Na+, K+, PO4 Most NB to replace is K+  Myocardial cell membrane stability  Risk of dysrhythmia, death

29 Electrolyte Replacement DKA – K+ may be normal or elevated Acidosis may lead to ‘false normal’ K+ levels True body K+ much lower Treatment of DKA may lead to lowering of K+  Insulin  HCO3

30 Electrolyte Replacement Hold insulin until you’ve checked the K+ Don’t give insulin if K+ < 3.3 mmol/L If K+ normal or high start rehydration and insulin K+ < 5.0 mmol add 20-40 mmol/L of K+ to IV fluids Ensure Mg+ supplemented as well

31 DKA – Treatment summary IV fluids – bolus ++ if shocky Check lytes  Replace K+ early  Add to IV fluid as K+ < 5.0 mmol/L Insulin infusion 0.1 units/kg/hr Look for inciting event…  Infection, MI, trauma, pancreatitis…

32 DKA - Treatment Bicarb is rarely indicated Risk of hypokalemia No proven indications Guidelines suggest that if:  pH < 7.0 – after 1 hour of treatment  Give one amp diluted in 200 cc over 1 hour

33 CASE 1-B 77 y F from nursing home Not eating or drinking lately Vague abdominal pain expressed to care home staff yesterday Didn’t come down for lunch

34 CASE 1-B EMS called when she was found in her room HR 120 BP 90/50 RR 18 Sat 98% GCS 9 Glucose ‘high’

35 CASE 1-B Labs:  Na+ 144 mmol/L  K+ 5.4 mmol/L  Cl- 124 mmol/L  HCO3 20 mmol/L  Glucose 49 mmol/L  Urea 15 mmol/L  VBG 7.34 / 40 / 90 / 21

36 Hyperosmolarity 2 Na+ + gluc + urea = osmolarity DKA osmo usually < 320 mmol/L HHS > 320 mmol/L

37 Hyperglycemic Hyperosmolar State Formerly known as HONK  Pts can have ketosis so misleading name Marked hyperglycemia and dehydration Profound electrolyte losses Due to insulin resistance and excess counter regulatory hormones

38 Hyperglycemic Hyperosmolar State More likely to occur in older, obese pts More often Type 2 DM May develop over days – weeks Frequent in elderly:  free water deprived  compromised renal fxn

39 Hyperglycemic Hyperosmolar State Some insulin present so no ketone production No subsequent acidosis (pH > 7.3)

40 Hyperglycemic Hyperosmolar State LOOK for underlying cause Older more frail pts  IV fluids  Insulin infusion  Monitoring and correction of electrolytes  K+ depleted but not as low as DKA No acidosis, so no shift

41 Diagnosis - Laboratory

42

43 Complications of DKA and HHS Cerebral Edema ARDS Hypoglycemia and Hypokalemia Thrombosis and PE  No RCT to tell us what to do  Venous stasis, viscous blood, underlying artherosclerosis – set up for clot  Consider Heparin sc for DVT prophylaxis in high risk patients

44 Prognosis - summary DKA mortality 4-10% HHA mortality 10-50%  Not as different as I always thought: IV fluids Lower glucose with IV insulin infusion Anticipate and correct electrolyte abnormalities (K+ most NB in DKA) Add glucose to IV at gluc < 15 mmol/L Look for precipitant

45 CASE 2 3 month old boy with gastroenteritis To ED with parents lethargic Has not been eating well Clinically looks dry Glucose 1.6 mmol/L  Tx: 4 cc/kg D10W  IV fluids, improved

46 CASE 3 25 y female Took her insulin 30 minutes ago to kill self Seizure in waiting room Tx: IV glucose  1 amp D50W  Additional amps as needed  May require infusion of D10W

47 CASE 4 27 year old Type 1 DM Took insulin this am as usual Skipped breakfast, then vigorous exercise Now confused, cant’ find keys EMS called

48 CASE 4 Initial glucose 2.2 mmol/L Vitals stable, GCS 13 Given IM glucagon and some oral CHO Now glucose is 6.6 mmol/L Feels well, A&O x 3 EMS patches to cancel transport  Alert, cooperative pts, responsible adults  Tolerating oral CHO

49 Hypoglycemia - Summary Bolus IV glucose  D50W adults (1-3 amps)  D25W peds (4 cc/kg)  D10W neonate-2 years (4 cc/kg) NO IV can give Glucagon IM 1-2 mg Prolonged hypoglycemia after OD of insulin may need Dextrose infusion D10W Treatment is eating CHO meals

50 CASE 5 55 year old male Type 2 DM Acting confused at home Wife called EMS Meds:  Metformin  Altace  Glyburide  ASA

51 CASE 5 Given IM glucagon and some juice Alert and oriented 25 minutes after EMS patches to ED to cancel transport

52 Pancreatic Beta Cell GLUCOSE K+ Ca+ INSULIN Sul-onlyurea

53 Oral Hypoglycemics Variety of classes Long half lives Potentiate action of beta cells to secrete insulin in setting of glucose Can have rebound hypoglycemia due to our treatments

54 Prospective, DBRCT Included hypoglycemia, on sulfonylureas Standard tx: 1 amp D50 and oral CHO placebo or octreotide (75 mcg sc)

55 Oral hypoglycemics - summary Tx acute hypoglycemia as expected Longer period of observation  Not just for ODs  Can happen with therapeutic use and change in drug clearance or increase in dose Need admission to hospital Octreotide 50 mcg SC q 6h if they have a rebound event Treatment is eating CHO

56 Hypoglycemia Check glucose as another vital sign Treat low glucose with boluses Oral feeding is most NB IM glucagon an option Octreotide for REBOUND event in oral hypoglycemic ingestion

57 DM - Emergencies HHS and DKA treatment is similar Avoid iatrogenic complications treat low glucose with bolus Monitor as appropriate

58 Questions?


Download ppt "DIABETIC EMERGENCIES Trevor Langhan MD January 31 st, 2008 University of Calgary."

Similar presentations


Ads by Google